FIELD: organic chemistry. SUBSTANCE: product of the formula (I) where R1 CH3,, C2H5, H-C3H7, H-C4H9, CH2= CH-CH2, CH = C-CH2, , CH3-C(Cl) = CH-CH2,, C6H5CH2;; R2= C6H5,, 4-Br-C6H4, 4-Cl-C6H4, C6H5CH = CH;; R3 H, COOH, COOR1 where R1 has meanings indicated above. Reagent 1: compounds of the general formula (II) or (III) where R2 and R3 have meanings indicated above. Reagent 2: halogenalkane of the formula R1X where R1 has meanings indicated above; X halogen. Reaction conditions: in superbasic medium using dimethylsulfoxide-water (9:1)-NaOH (5-10%), or under conditions of interphase catalysis at the molar ratio of compound (II) (III) halogenalkane triethylbenzylammonium chloride 1: (5-6):1. Synthesized compounds show antiinflammatory and antitumor effects and can be used as intermediate substances for synthesis of sedative drugs. EFFECT: improved method of synthesis. 6 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING 2-ACYLINDOLES | 0 |
|
SU825521A1 |
METHOD OF PREPARING ACYLINDOL-3-CARBOXYLIC ACIDS | 0 |
|
SU696016A1 |
HETEROCYCLIC DERIVATIVES OR THEIR SALTS WITH ACIDS OR BASES | 1990 |
|
RU2049784C1 |
CONDENSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS | 2011 |
|
RU2576660C2 |
POLYMER, ESSENTIALLY RADIOPAQUE PRODUCTS FOR EMBOLIC THERAPY | 2004 |
|
RU2373958C2 |
IMMUNOFYLLINE-SPECIFIC LIGANDS AS ANTIASTHMATIC AND IMMUNO-DEPRESSANT AGENTS AND METHOD OF THEIR SYNTHESIS, PHARMACEUTICALLY READY FORM, MEDICINAL AGENT AND METHOD OF ITS PREPARING | 1997 |
|
RU2172743C2 |
SWEETENING AGENT AND A METHOD OF ITS SYNTHESIS | 1990 |
|
RU2053239C1 |
2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PRODUCTION AND APPLICATION | 2012 |
|
RU2632903C2 |
PROCESS OF TREATMENT OF WATER-CARRYING WELLS IN GAS FIELDS AND OF WELLS OF UNDERGROUND GAS STORAGES | 1998 |
|
RU2163667C2 |
DIPEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHODS OF THEIR SYNTHESIS, ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2098424C1 |
Authors
Dates
1995-11-10—Published
1991-12-09—Filed